TY  - JOUR 
AU  - Caballero, M. D.
AU  - Rubio, V.
AU  - Rifon, J.
AU  - Heras, I.
AU  - García Sanz, Ramón
AU  - Vázquez López, María Lourdes
AU  - Vidriales Vicente, María Belén
AU  - Cañizo Fernández-Roldán, María Consuelo del
AU  - Corral, M.
AU  - González Díaz, Marcos
AU  - León, A.
AU  - Jean-Paul, E.
AU  - Rocha, E.
AU  - Moraleda, J. M.
AU  - San Miguel Izquierdo, Jesús Fernando
PY  - 1997
SN  - 0268-3369
UR  - http://hdl.handle.net/10366/155435
AB  - [EN]In the present paper, we evaluate tolerability, outcome and prognostic factors in patients with poor prognosis non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) when uniformly treated with BCNU, etoposide, cytarabine and melphalan (BEAM) and...
LA  - eng
PB  - Nature
KW  - Bone Marrow
KW  - Transplantation
KW  - Lymphoma
KW  - Treatment
KW  - Hematopoietic Stem Cell Transplantation
KW  - Adult
KW  - Humans
KW  - Adolescent
KW  - Hodgkin Disease
KW  - Melphalan
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Cytarabine
KW  - Middle Aged
KW  - Carmustine
KW  - Prognosis
KW  - Lymphoma
KW  - Graft Survival
KW  - Treatment Outcome
KW  - Podophyllotoxin
KW  - Bone Marrow Transplantation
TI  - BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors
DO  - 10.1038/sj.bmt.1700913
T2  - Bone Marrow Transplantation
VL  - 20
M2  - 451
ER  -